Behavioral and Electrophysiological Evidence of the Modulation of Fatigue in Multiple Sclerosis, Relapsing Remitting Form: a Pilot Study

CompletedNot a drug-phase studyRelapsing MSNCT07624812

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • TENS therapy

What it measured

Main measures

  • Motor performance

    baseline

Other measures (1)

  • Readiness Potential

    baseline

    Nerve conduction tests

Who could take part

Relapsing MS · 18 to 40 · EDSS 2 to 5.5

Show the full criteria

Inclusion criteria

i) right-hand dominant; ii) diagnosis of MS, Relapsing-Remitting (RR-) form (Polman et al., 2011); iii) score at the EDSS (Kurtzke, 1983) from 2 to 5.5.

Exclusion criteria

i) relapse occurring over the previous six months; ii) a history of illness not less than one year; iii) first dose of disease-modifying or symptomatic treatments and any medication change in the previous three months; iv) reporting a score of equal to 2 or more at FSS (Kurtzke, 1983) cerebellar and brainstem scales; v) neuroimaging evidence of MS lesions at the spinal cord; vi) any known psychiatric or other neurological disorders, history of head injury, or stroke; vii)a score \< 24 (Lezak et al., 2004) at the Italian version (Magni et al., 1995) at the MMSE (Folstein et al., 1975).

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

To furnish behavioral and electrophysiological evidence of the possible modulation of fatigue in Multiple Sclerosis - relapsing remitting form, through a verbal placebo.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jan 2025

    2. Main results due

      Apr 2026

    3. Finished

      Apr 2026

    Assembled by software from public sources.